Exemestane

Resumen de Ensayos Clínicos

2 ensayos encontrados
Sobre Exemestane

Se está recopilando información detallada sobre este medicamento.

Categoría Otros Medicamentos
2
Total Ensayos
1
Reclutando
1
Activo
0
Completado
1,073
Inscripción Total
15
Países
Centros activos para Exemestane
Centros reclutando 15 países
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
NCT05768139 Fase 1 Reclutando 880 pacientes
Inicio: Apr 2023
Fin: Jul 2030
Intervencional
Medicamentos: Abemaciclib Anastrozole Exemestane Fulvestrant Imlunestrant Letrozole Metformin Palbociclib Ribociclib STX-478 Tamoxifen
Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of STX-478 (LY4064809) in participants with advanced solid tumors with P13Ka muta...
United States, Belgium, France, Germany, Ireland, Italy, Japan, Netherlands, Spain
Ver Detalles ClinicalTrials.gov ¿Soy elegible?
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
NCT05307705 Fase 1 Activo 193 pacientes
Inicio: May 2022
Fin: Dec 2026
Intervencional
Medicamentos: Abemaciclib Anastrozole Exemestane Fulvestrant Imlunestrant LOXO-783 Paclitaxel
The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-783. LOXO-783 may be used to treat breast cancer and other solid tumors that have a change in a particular gene (known as the PIK3CA gene). Part...
United States, Australia, Belgium, Canada, China, France, Germany, Japan, Singapore, South Korea, Sp
Ver Detalles ClinicalTrials.gov ¿Soy elegible?
Volver al Glosario Ver Todos los Ensayos Filtrar Reclutando